Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
74.31
-1.68 (-2.21%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical
336.41M
Log In
Log In
Log In
Pharmaceutical Growth
88.07%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
274.17M
Log In
Log In
Log In
United States Growth
86.89%
Log In
Log In
Log In
Rest of the World
62.24M
Log In
Log In
Log In
Rest of the World Growth
93.43%
Log In
Log In
Log In